J.P. Morgan on Wednesday upgraded Illumina (ILMN) to Overweight from Neutral and raised its December 2026 price target to $185 from $125, citing a favorable outlook for the gene sequencing company ...
SAN DIEGO, May 28, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) and SPT Labtech today introduced the fireflyGO automation platform, a new benchtop liquid handling and library preparation ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Just two months after announcing it would be laying off dozens of its San Diego employees, gene sequencing giant Illumina said it plans let go of 172 more workers. In paperwork filed last week with ...
Management raised full-year guidance, with Dhingra stating, "We are raising our reported revenue guidance by $20 million... and now expect revenue of $4.52 billion to $4.62 billion" and "now expect ...
Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. Illumina became a genomics juggernaut by developing machines that could read large ...
Illumina Inc. said the Chinese government has lifted a ban on the company selling its DNA sequencing machines inside the country. The move is a reversal from China’s previous position, which blocked ...
"Illumina has inflicted substantial harm on Element, resulting in lost sales, diminished market share, and reduced profits," counsel for DNA-sequencing company Element Biosciences Inc. alleged in an ...
Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. SAN DIEGO — A year ago, Illumina CEO Jacob Thaysen laid out a plan for the genomics ...
Less than two years after Boulder-based biotech firm SomaLogic Inc. merged with Standard BioTools Inc. (Nasdaq: LAB), Illumina Inc. (NASDAQ: ILMN) has inked a deal to absorb SomaLogic’s business in an ...
Illumina said the acquisition of SomaLogic will bolster its multiomics strategy to move beyond DNA sequencing, while Standard BioTools said the turnaround sale gives it an opportunity to break even ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results